<!DOCTYPE HTML>
<!DOCTYPE html PUBLIC "" ""><HTML lang="en" lang="en" xml:lang="en" xmlns="http://www.w3c.org/1999/xhtml"><HEAD><META 
content="IE=11.0000" http-equiv="X-UA-Compatible">
     
<META http-equiv="content-type" content="text/html; charset=utf-8">     
<TITLE>ALB_CR_H</TITLE>     
<META name="title" content="NHANES 2013-2014: Albumin &amp; Creatinine - Urine Data Documentation, Codebook, and Frequencies"> 
    
<STYLE type="text/css">
					.nhanes-doc { font: 75% Verdana, Arial, Helvetica, sans-serif; }

					.nhanes-doc h1 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 2em;
					font-weight: normal;
					margin-bottom: 10px;
					margin-top: 0;
					}

					.nhanes-doc h2 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.6em;
					font-weight: normal;
					}

					.nhanes-doc h3 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.5em;
					font-weight: normal;
					}

					.nhanes-doc h3.vartitle {
					background-color: #c1d5b0;
					padding: 6px 12px;
					}

					.nhanes-doc h4 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.3em;
					font-weight: bold;
					}

					.nhanes-doc h5 {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					font-weight: bold;
					}

					.nhanes-doc h5.specialnote {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1.2em;
					font-style: italic;
					font-weight: bold;
					}

					.nhanes-doc a {
					color: #039;
					text-decoration: none;
					}

					.nhanes-doc p {
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					line-height: 1.33em;
					margin: 0 3em 1em;
					padding: 0;
					text-align: left;
					}

					.nhanes-doc ul {
					list-style-type: disc;
					margin: 0 3em 1em;
					padding: 0;
					}

					.nhanes-doc ol {
					list-style-type: decimal;
					margin: 0;
					overflow: hidden;
					padding: 0;
					padding-left: 2em;
					}

					.nhanes-doc li {
					margin-left: 1.5em;
					margin-top: 0.7em;
					}

					.nhanes-doc table {
					border: #000 1px solid;
					border-collapse: collapse;
					margin: 0 auto 1em;
					max-width: 600px;
					padding: 2px;
					page-break-inside: avoid;
					table-layout: auto;
					}

					.nhanes-doc th {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc th.rowheader {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc td {
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: left;
					vertical-align: top;
					}

					.nhanes-doc td.values2 {
					text-align: RIGHT;
					vertical-align: top;
					}

					.nhanes-doc table caption {
					font-weight: bold;
					padding-bottom: 0.5em;
					}

					.nhanes-doc div#wrapper { width: 650px; }

					.nhanes-doc div#toc {
					border: solid 1px #CCC;
					float: left;
					height: 95%;
					left: 750px;
					overflow: hidden;
					position: fixed;
					top: 10px;
					width: 400px;
					z-index: 10;
					}

					.nhanes-doc div#toc h3 {
					background-color: #f4f4e1;
					border-bottom: solid 1px #ccc;
					letter-spacing: 8px;
					margin: 0;
					padding: 8px;
					text-align: center;
					text-transform: uppercase;
					}

					.nhanes-doc div#toc-scroll {
					height: calc(100% - 1.5em);
					overflow: scroll;
					width: 100%;
					}

					.nhanes-doc div#toc li {
					margin-left: -0.5em;
					margin-right: -0.5em;
					}

					.nhanes-doc div#PageHeader {
					border-bottom: thin solid #999;
					margin-bottom: 12px;
					width: 650px;
					}

					.nhanes-doc div#Sections { width: 650px; }

					.nhanes-doc div#Codebook { width: 650px; }

					.nhanes-doc div#Codebook dl {
					margin: 2em 0 10px 40px;
					padding: 0;
					width: 600px;
					display: table;
					}

					.nhanes-doc div#Codebook dt {
					float: left;
					font-weight: bold;
					margin: 0;
					padding: 0.5em;
					width: 150px;
					display: table-cell;
					}

					.nhanes-doc div#Codebook dd {
					float: left;
					margin: 0;
					padding: 0.5em;
					width: 420px;
					display: table-cell;
					}

					.nhanes-doc div#References {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc div#Appendix {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc table.values {
					border: 2px;
					left: 20px;
					margin-bottom: 20px;
					page-break-inside: avoid;
					position: relative;
					width: 600px;
					}

					.nhanes-doc span.file-size { color: gray; }

					.nhanes-doc .pagebreak {
					background-color: transparent;
					display: block;
					page-break-after: always;
					page-break-inside: avoid;
					}
				</STYLE>
     
<STYLE type="text/css" media="print">
					.nhanes-doc div#toc { display: none; }
				</STYLE>
   </HEAD>   
<BODY class="nhanes-doc">
<DIV id="toc">
<H3>Table of Contents</H3>
<DIV id="toc-scroll">
<UL>
  <LI><A href="#Component_Description">Component Description</A>           </LI>
  <LI><A href="#Eligible_Sample">Eligible Sample</A>           </LI>
  <LI><A href="#Description_of_Laboratory_Methodology">Description of Laboratory 
  Methodology</A>           </LI>
  <LI><A href="#Laboratory_Method_Files">Laboratory Method Files</A>           
  </LI>
  <LI><A href="#Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality 
  Assurance and Monitoring</A>           </LI>
  <LI><A href="#Data_Processing_and_Editing">Data Processing and Editing</A>     
        </LI>
  <LI><A href="#Analytic_Notes">Analytic Notes</A>           </LI>
  <LI><A href="#References">References</A>           </LI>
  <LI><A href="#Codebook">Codebook</A>             
  <UL id="CodebookLinks">
    <LI><A href="#SEQN">SEQN - Respondent sequence number</A>               
</LI>
    <LI><A href="#URXUMA">URXUMA - Albumin, urine (ug/mL)</A>               
</LI>
    <LI><A href="#URXUMS">URXUMS - Albumin, urine (mg/L)</A>               </LI>
    <LI><A href="#URXUCR">URXUCR - Creatinine, urine (mg/dL)</A>               
    </LI>
    <LI><A href="#URXCRS">URXCRS - Creatinine, urine (umol/L)</A>               
    </LI>
    <LI><A href="#URDACT">URDACT - Albumin creatinine ratio (mg/g)</A>           
        </LI></UL></LI></UL></DIV></DIV>
<DIV id="wrapper">
<DIV id="PageHeader">
<H1>National Health and Nutrition Examination Survey</H1>
<H2>2013-2014 Data Documentation, Codebook, and Frequencies</H2>
<H3>Albumin &amp; Creatinine - Urine (ALB_CR_H)</H3>
<H4> Data File: ALB_CR_H.xpt</H4>
<H5 class="left">First Published: October 2015</H5>
<H5 class="right">Last Revised: September 2016</H5></DIV>
<DIV id="Sections">
<H2 id="Component_Description">Component Description</H2>
<P>Urinary albumin and urinary creatinine are measured in a random urine 
collected in the MEC (first collection).</P>
<P>Albumin measurements are used in the diagnosis and treatment of diseases 
involving the liver and/or kidneys. These measurements are frequently used to 
assess nutritional status, due to plasma levels of albumin being dependent on 
protein intake. Increased microalbuminuria is a sign of renal disease and may be 
predictive of nephropathy risk in patients with type 1 and type 2 diabetes. It 
is also associated with hypertension and cardiac disease.</P>
<P>Creatinine is produced by creatine and creatinine phosphate as a result of 
muscle metabolic processes. It is then excreted by glomerular filtration during 
normal renal function. Creatinine may be measured in both serum and urine. 
Creatinine measurement is useful in the diagnosis and treatment of renal 
diseases, in monitoring renal dialysis, and as a calculation basis for other 
urinary analytes (e.g., total protein and microalbumin).</P>
<H2 id="Eligible_Sample">Eligible Sample</H2>
<P>Examined participants aged 6 years and older were eligible.</P>
<H2 id="Description_of_Laboratory_Methodology">Description of Laboratory 
Methodology</H2>
<P>Urine specimens are processed, stored and shipped to University of Minnesota, 
Minneapolis, MN for analysis.</P>
<P><STRONG>Urinary Albumin</STRONG></P>
<P>A solid-phase fluorescent immunoassay for the measurement of human urinary 
albumin is described by Chavers et al. (Chavers, BM, Kidney Int. 1984; 
25:576–578). The fluorescent immunoassay is a non-competitive, double-antibody 
method for the determination of human albumin in urine. Antibody to human 
albumin is covalently attached to derivatized polyacrylamide beads. The 
solid-phase antibody is reacted with a urine specimen, and the urine 
albumin-antigen complexes with the solid-phase antibody. This complex then 
reacts with fluorescein-labeled antibody. The unattached fluorescent antibody is 
then removed by washing during centrifugation. The fluorescence of the stable 
solid-phase antibody complex is determined with a fluorometer; the fluorescence 
is directly proportional to the amount of urine albumin present. The standard 
curve is 0.5–20 μg/mL of albumin.</P>
<P>Results of the fluorescent immunoassay (FIA) are reproducible, and the test 
is accurate and sensitive for the detection of human urinary albumin excretion. 
It is especially useful for the measurement of low levels of urinary albumin not 
detectable by dipstick methods. The FIA assay resembles the radio-immunoassay 
(RIA) in technique and sensitivity without the potential health hazards 
associated with the handling of isotopes in the laboratory (Chavers, BM, Kidney 
Int. 1984; 25:576–578). </P>
<P><STRONG>Urinary Creatinine</STRONG></P>
<P>Creatinine is produced by creatine and creatinine phosphate as a result of 
muscle metabolic processes. It is then excreted by glomerular filtration during 
normal renal function. Creatinine may be measured in both serum and urine. 
Creatinine measurement is useful in the diagnosis and treatment of renal 
diseases, in monitoring renal dialysis, and as a calculation basis for other 
urinary analytes (e.g. total protein, microalbumin).</P>
<P>In this enzymatic method creatinine is converted to creatine under the 
activity of creatininase. Creatine is then acted upon by creatinase to form 
sarcosine and urea. Sarcosine oxidase converts sarcosine to glycine and hydrogen 
peroxide, and the hydrogen peroxide reacts with chromophore in the presence of 
peroxidase to produce a color product that is measured at 546 nm (secondary 
wavelength = 700 nm). This is an endpoint reaction that agrees well with 
recognized HPLC methods, and it has the advantage over Jaffe picric acid-based 
methods that are susceptible to interferences from non-creatinine 
chromogens.</P>
<P>Refer to the Laboratory Method Files section for detailed laboratory 
procedure manual(s) of the methods used.</P>
<P>There were no changes lab equipment, or lab site for this component in the 
NHANES 2013-2014 cycle for albumin.  However, there was a change to the 
chemistry analyzer for creatinine measurements.  In 2011-2012 creatinine was 
measured on the Roche/Hitachi Mod P but in 2013-2014 creatinine was measured on 
the Roche/Hitachi Cobas 6000 chemistry analyzer.&nbsp;</P>
<P>Detailed instructions on specimen collection and processing can be found in 
the NHANES <A href="https://wwwn.cdc.gov/nchs/data/nhanes/2013-2014/manuals/2013_mec_laboratory_procedures_manual.pdf">Laboratory/Medical 
Technologists Procedures Manual (LPM)</A>.</P>
<H2 id="Laboratory_Method_Files">Laboratory Method Files</H2>
<P><A href="https://wwwn.cdc.gov/nchs/data/nhanes/2013-2014/labmethods/ALB_CR_H_met_albumin.pdf" 
target="_blank">Urinary Albumin</A>           <SPAN> (October 2015)</SPAN>       
  </P>
<P><A href="https://wwwn.cdc.gov/nchs/data/nhanes/2013-2014/labmethods/ALB_CR_H_MET_URINE_CREATINE.pdf" 
target="_blank">Urinary Creatinine</A>           <SPAN> (October 2015)</SPAN>    
     </P>
<H2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality 
Assurance and Monitoring</H2>
<P>Urine specimens were processed, stored, and shipped to University of 
Minnesota, Minneapolis, MN for analysis. </P>
<P>Detailed instructions on specimen collection and processing are discussed in 
the NHANES <A href="https://wwwn.cdc.gov/nchs/data/nhanes/2013-2014/manuals/2013_mec_laboratory_procedures_manual.pdf">Laboratory 
Procedures Manual (LPM)</A>. Vials are stored under appropriate frozen (-30°C) 
conditions until they are shipped to University of Minnesota for testing.</P>
<P>The NHANES quality assurance and quality control (QA/QC) protocols meet the 
1988 Clinical Laboratory Improvement Act mandates. Detailed QA/QC instructions 
are discussed in the NHANES <A href="https://wwwn.cdc.gov/nchs/data/nhanes/2013-2014/manuals/2013_mec_laboratory_procedures_manual.pdf">LPM</A>.</P>
<P><STRONG>Mobile Examination Centers (MECs)</STRONG></P>
<P>Laboratory team performance is monitored using several techniques. NCHS and 
contract consultants use a structured quality assurance evaluation during 
unscheduled visits to evaluate both the quality of the laboratory work and the 
quality-control procedures. Each laboratory staff member is observed for 
equipment operation, specimen collection and preparation; testing procedures and 
constructive feedback are given to each staff member. Formal retraining sessions 
are conducted annually to ensure that required skill levels were maintained.</P>
<P><STRONG>Analytical Laboratories</STRONG></P>
<P>NHANES uses several methods to monitor the quality of the analyses performed 
by the contract laboratories. In the MEC, these methods include performing blind 
split samples collected on “dry run” sessions. In addition, contract 
laboratories randomly perform repeat testing on 2% of all specimens.</P>
<P>NCHS developed and distributed a quality control protocol for all the 
contract laboratories which outlined the use of Westgard rules (Westgard et al., 
1981) when running NHANES specimens. Progress reports containing any problems 
encountered during shipping or receipt of specimens, summary statistics for each 
control pool, QC graphs, instrument calibration, reagents, and any special 
considerations are submitted to NCHS quarterly. The reports are reviewed for 
trends or shifts in the data. The laboratories are required to explain any 
identified areas of concern.</P>
<P>All QC procedures recommended by the manufacturers were followed. Reported 
results for all assays meet the University of Minnesota quality control and 
quality assurance performance criteria for accuracy and precision, similar to 
the Westgard rules.</P>
<H2 id="Data_Processing_and_Editing">Data Processing and Editing</H2>
<P>The data were reviewed. Incomplete data or improbable values were sent to the 
performing laboratory for confirmation.</P>
<P>URDACT, the urine albumin/creatinine ratio was created in this data file:</P>
<P>The random urine albumin (URXUMA) in ug/mL and urine creatinine (URXUCR) in 
mg/dL were converted to the albumin/creatinine ratio (URDACT) in mg/g:</P>
<P><SPAN style="text-decoration: underline;">URDACT = URXUMA/URXUCR x 100, round 
to .01</SPAN></P>
<H2 id="Analytic_Notes">Analytic Notes</H2>
<P>Refer to the <A href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2013">2013 
- 2014 Laboratory Data Overview</A> for general information on NHANES laboratory 
data.</P>
<P>The analysis of NHANES laboratory data must be conducted using the 
appropriate survey design and demographic variables. The NHANES <A href="https://wwwn.cdc.gov/nchs/nhanes/2013-2014/fastqx_h.htm">2013-2014 
Demographics File</A> contains demographic data, health indicators, and other 
related information collected during household interviews as well as the sample 
design variables. The recommended procedure for variance estimation requires use 
of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively) in the 
demographic data file.</P>
<P>This laboratory data file can be linked to the other NHANES data files using 
the unique survey participant identifier (i.e., SEQN).</P>
<P><STRONG>Detection Limits</STRONG></P>
<P>The detection limits were constant for all of the analytes in the data set. 
Two variables are provided for each of these analytes. The variable name ending 
in “LC” (ex., URXUMALC) indicates whether the result was below the limit of 
detection: the value “0” means that the result was at or above the limit of 
detection, “1” indicates that the result was below the limit of detection.  For 
analytes with analytic results below the lower limit of detection (ex., 
URXUMALC=1), an imputed fill value was placed in the analyte results field. This 
value is the lower limit of detection divided by the square root of 2 
(LLOD/sqrt[2]). The other variable prefixed URX (ex., URXUMA) provides the 
analytic result for that analyte.</P>
<P>The lower limit of detection (LLOD) in ug/ml for albumin and in mg/dL for 
creatinine is:</P>
<TABLE>
  <TBODY>
  <TR>
    <TD><STRONG>Variable Name&nbsp;</STRONG></TD>
    <TD><STRONG>SAS Label&nbsp;</STRONG></TD>
    <TD><STRONG>&nbsp;LLOD</STRONG></TD></TR>
  <TR>
    <TD>&nbsp;URXUMA</TD>
    <TD>&nbsp;Albumin, Urine</TD>
    <TD>&nbsp;0.30 µg/mL</TD></TR>
  <TR>
    <TD>&nbsp;URXUCR</TD>
    <TD>&nbsp;Creatinine, urine (mg/dL)</TD>
    <TD>&nbsp;5.00&nbsp;mg/dL</TD></TR></TBODY></TABLE>
<P>Exam sample weights should be used for analyses. Please refer to the <A href="http://www.cdc.gov/nchs/data/nhanes/analytic_guidelines_11_12.pdf ">NHANES 
Analytic Guidelines </A>and the on-line <A href="https://www.cdc.gov/nchs/tutorials/" 
target="_blank">NHANES Tutorial</A> for further details on the use of sample 
weights and other analytic issues.</P></DIV>
<DIV id="References">
<H2>References</H2>
<UL>
  <LI>Burtis,CA, Ashwood, EA, Bruns, DE, eds. Tietz Textbook of Clinical 
  Chemistry and Molecular Diagnosis. Elsevier Inc., 2006.</LI>
  <LI>Chavers BM, Simonson J, Michael AF. A solid-phase fluorescent immunoassay 
  for the measurement of human urinary albumin. Kidney Int. 
1984;25:576–578.</LI>
  <LI>Creatinine Measurement Module Operating and Service Instructions, Beckman 
  ASTRA. Brea (CA): Beckman Instruments, Inc., 1979.</LI>
  <LI>Kaplan LA, Pesce AJ, editors, Clinical Chemistry Theory, Analysis and 
  Correlation. St. Louis: CV Mosby Company, 1984:416–1261.</LI>
  <LI>Maintenance Guide, Beckman ASTRA. Brea (CA): Beckman Instruments, Inc., 
  1982.</LI>
  <LI>National Kidney Foundation. K/DOQI Clinical Practice Guidelines for 
  Chronic Kidney Disease: Evaluation, Classification and Stratification. Table 
  14: Prevalence of Stages of Chronic Kidney Disease and Levels of Kidney 
  Function in the US. Am J Kidney Dis 39:S1-S266, 2002 (suppl 1).</LI>
  <LI>NHANES Laboratory Procedural Manual. Section 5: Urine Specimen Collection 
  and Processing, 
  https://wwwn.cdc.gov/nchs/data/nhanes/2009-2010/manuals/lab.pdf <BR> NHANES 
  home urine collection manual Available From: <A href="https://wwwn.cdc.gov/nchs/data/nhanes/2009-2010/manuals/homeurine.pdf">https://wwwn.cdc.gov/nchs/data/nhanes/2009-2010/manuals/homeurine.pdf</A>[Accessed: 
  February 2012]</LI>
  <LI>Operating and Service Instructions, Beckman ASTRA. Brea (CA): Beckman 
  Instruments, Inc., 1986.</LI>
  <LI>Tietz NW, editor, Textbook of Clinical Chemistry. Philadelphia: WB 
  Saunders Company, 1986;775–1392.</LI>
  <LI>Westgard J.O., Barry P.L., Hunt M.R., Groth T. A multi-rule Shewhart chart 
  for quality control in clinical chemistry. Clin Chem (1981) 
27:493-501.</LI></UL></DIV>
<DIV id="Codebook">
<H2>Codebook and Frequencies</H2>
<DIV class="pagebreak">
<H3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">SEQN</DD>
  <DT>SAS Label: </DT>
  <DD>Respondent sequence number</DD>
  <DT>English Text: </DT>
  <DD class="info">Respondent sequence number.</DD>
  <DT>Target: </DT>
  <DD> Both males and females 6 YEARS -			150 YEARS</DD></DL></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="URXUMA">URXUMA - Albumin, urine (ug/mL)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">URXUMA</DD>
  <DT>SAS Label: </DT>
  <DD>Albumin, urine (ug/mL)</DD>
  <DT>English Text: </DT>
  <DD class="info">Albumin, urine (ug/mL)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 6 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">0.21 to 9600</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">8052</TD>
    <TD align="right" class="values">8052</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">239</TD>
    <TD align="right" class="values">8291</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="URXUMS">URXUMS - Albumin, urine (mg/L)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">URXUMS</DD>
  <DT>SAS Label: </DT>
  <DD>Albumin, urine (mg/L)</DD>
  <DT>English Text: </DT>
  <DD class="info">Albumin, urine (mg/L)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 6 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">0.21 to 9600</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">8052</TD>
    <TD align="right" class="values">8052</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">239</TD>
    <TD align="right" class="values">8291</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="URXUCR">URXUCR - Creatinine, urine (mg/dL)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">URXUCR</DD>
  <DT>SAS Label: </DT>
  <DD>Creatinine, urine (mg/dL)</DD>
  <DT>English Text: </DT>
  <DD class="info">Creatinine, urine (mg/dL)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 6 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">5 to 659</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">8052</TD>
    <TD align="right" class="values">8052</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">239</TD>
    <TD align="right" class="values">8291</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="URXCRS">URXCRS - Creatinine, urine (umol/L)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">URXCRS</DD>
  <DT>SAS Label: </DT>
  <DD>Creatinine, urine (umol/L)</DD>
  <DT>English Text: </DT>
  <DD class="info">Creatinine, urine (umol/L)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 6 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">442 to 58255.6</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">8052</TD>
    <TD align="right" class="values">8052</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">239</TD>
    <TD align="right" class="values">8291</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="URDACT">URDACT - Albumin creatinine ratio (mg/g)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">URDACT</DD>
  <DT>SAS Label: </DT>
  <DD>Albumin creatinine ratio (mg/g)</DD>
  <DT>English Text: </DT>
  <DD class="info">Albumin creatinine ratio (mg/g)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 6 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">0.21 to 9000</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">8052</TD>
    <TD align="right" class="values">8052</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">239</TD>
    <TD align="right" class="values">8291</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV></DIV></DIV></BODY></HTML>
